Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intratympanic Injections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02768662
What this trial is testing

A 6-Month Extension Study of OTO-104 in Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 142
Post-approval studies (Phase 4)Ended earlyNCT04226456
What this trial is testing

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Who this might be right for
Ototoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicity+1 more
Centre Hospitalier Universitaire Saint Pierre 19
Testing effectiveness (Phase 2)Study completedNCT05086276
What this trial is testing

FX-322 in Adults With Acquired Sensorineural Hearing Loss

Who this might be right for
Hearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss
Frequency Therapeutics 142
Testing effectiveness (Phase 2)Study completedNCT03918109
What this trial is testing

OTO-313 in Subjects With Subjective Tinnitus

Who this might be right for
Tinnitus, Subjective
Otonomy, Inc. 43
Early research (Phase 1)Study completedNCT04629664
What this trial is testing

FX-322 in Adults With Severe Sensorineural Hearing Loss

Who this might be right for
Hearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss
Frequency Therapeutics 31
Testing effectiveness (Phase 2)Study completedNCT03616223
What this trial is testing

FX-322 in Sensorineural Hearing Loss

Who this might be right for
Sensorineural Hearing Loss
Frequency Therapeutics 23
Testing effectiveness (Phase 2)Study completedNCT01412177
What this trial is testing

OTO-104 for the Treatment of Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 154
Testing effectiveness (Phase 2)Study completedNCT04829214
What this trial is testing

OTO-313 in Subjects With Unilateral Subjective Tinnitus

Who this might be right for
Subjective Tinnitus
Otonomy, Inc. 153
Testing effectiveness (Phase 2)Study completedNCT04766853
What this trial is testing

Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss

Who this might be right for
Hearing Loss, SuddenHearing Loss, OtotoxicHearing Loss, Noise-Induced+1 more
Seoul National University Hospital 15
Not applicableStudy completedNCT06885723
What this trial is testing

Use of Vibration Anesthesia Device in Intratympanic Injections

Who this might be right for
Intratympanic InjectionsSudden Hearing Loss
Yuzuncu Yil University 40
Early research (Phase 1)Study completedNCT01755286
What this trial is testing

OTO-201 for Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement

Who this might be right for
Bilateral Middle Ear Effusion Requiring Tympanostomy Tube Placement
Otonomy, Inc. 83
Large-scale testing (Phase 3)Study completedNCT03508440
What this trial is testing

Intratympanic Steroid for Bell's Palsy

Who this might be right for
Bell's PalsyFacial Nerve Paresis
University of Missouri-Columbia 10
Large-scale testing (Phase 3)Looking for participantsNCT05851508
What this trial is testing

The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease

Who this might be right for
Meniere Disease
Leiden University Medical Center 148
Early research (Phase 1)Study completedNCT01084525
What this trial is testing

OTO-104 for Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 44